Small Molecules
6 September 2017
Pharmaxis announces anti fibrotic LOXL2 program clears preclinical development and set to commence phase 1 trials5 September 2017
Summit Therapeutics plc : Positive Top-line Phase 2 Results5 September 2017
H3 Biomedicine Announces First Patient Dosed with H3B-6545 in Phase 1 Study in Breast Cancer5 September 2017
Ortho Dermatologics Submits New Drug Application To The U.S. Food And Drug Administration For Psoriasis Treatment IDP-1185 September 2017
Ligand Announces Top-Line Results from Phase 2 Study of LGD-6972 in Patients with Type 2 Diabetes5 September 2017
Mavenclad (Cladribine Tablets) Demonstrates Sustained Disease Control over 4 Years with Maximum of Only 20 Days Oral Treatment5 September 2017
Novartis landmark Phase III trial shows fingolimod significantly reduces relapses in children and adolescents with MS5 September 2017
ReViral initiates Phase 2a study of RV521 for treatment of Respiratory Syncytial Virus31 August 2017
Sunovion Submits New Drug Application for Dasotraline to the FDA for the Treatment of Patients with ADHD30 August 2017
Otonomy Reports Results for AVERTS-1 Phase 3 Trial for OTIVIDEX™ in Patients with Ménière’s Disease30 August 2017
FDA approves new antibacterial drug30 August 2017
FDA approves first U.S. treatment for Chagas disease29 August 2017
Bayer announces enrollment of first U.S. patient in Phase III trials of vilaprisan in uterine fibroids29 August 2017
Chi-Med Initiates a Phase I Clinical Trial of Selective PI3Kδ Inhibitor HMPL-689 in Lymphoma Patients in China29 August 2017
AVEO Oncology Announces FOTIVDA® (tivozanib) Approved in the European Union for the Treatment of Advanced Renal Cell CarcinomaNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports